Pihu Kumari-wide_v1.jpg

Changing Diabetes® in Children

The Changing Diabetes® in Children (CDiC) programme ensures care and life-saving medicine for children with type 1 diabetes in low and middle income countries. It aims at changing the future for children with type 1 diabetes in these countries. Because no child should die of diabetes! 

 


Reaching 20,000 children

When limited public health data exist on children with type 1 diabetes, the unbearable truth is that only few children live long enough to make it into the registries in low and middle income countries.

As a global leader in diabetes care, we took it upon us to reach 10,000 children with type 1 diabetes living in resource-poor settings when the CDiC programme was initiated in 2009. Since then, we have trained more than 8,500 healthcare providers and enrolled over 14,000 children in nine countries who now live active lives and are educated to take care of their condition.

The original ambition has been doubled to reach 20,000 children with type 1 diabetes by 2020, by expanding the programme to five new countries in 2017.

 

 

The CDiC is a public-private partnership programme between Novo Nordisk, Roche, the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the World Diabetes Foundation (WDF). It is being implemented by local partners and national ministries of health. 


Educate yourself

If you live with type 1 diabetes, are a parent or if you treat someone with the condition, you probably have questions like:

 

- Why do I need insulin? - How much insulin should I take and where do I inject it? - How can I measure my blood glucose? - What are hypo- and hyperglycaemia and how to recognise them? - Which foods should I eat? What is my role as a nurse or doctor and how can I best treat and support my patients?

 

Click on the icons below to get your questions answered (available for download in English, French, Spanish, Swahili, Amharic and Hindi):

 


About type 1 diabetes

An estimated 542,000 children under the age of 15 are living with type 1 diabetes around the world with an expected 86,000 new cases each year. Many of them live in low- and middle-income countries (IDF, 2015).

Unlike type 2 diabetes, type 1 diabetes is not lifestyle-related and there is no known way to prevent it. People with type 1 diabetes cannot survive without daily doses of insulin and must adhere to a structured self-management plan. In many low-resource countries, children lack access to insulin, blood glucose monitoring and appropriately trained health professionals. This can lead to poor blood glucose control and subsequent severe health complications and early death.